文献速递垂体与肾上腺疾病

库欣综合征伴高血压患者尿细胞外囊泡钠转运蛋白增加

Increased Urinary Extracellular Vesicle Sodium Transporters in Cushing Syndrome With Hypertension.
PubMed 文献 · J Clin Endocrinol Metab · 2018-01-01

该观察性研究在10例库欣综合征(CS)伴高血压患者和7名年龄匹配健康对照中,用超离心分离尿细胞外囊泡(uEVs)并行免疫印迹分析肾钠转运蛋白。结果显示仅RAAS受抑制的CS患者uEVs中pNKCC2及总/磷酸化NCC升高,且血钾与这些转运蛋白相关;治疗CS可逆转上述升高。

要点

  • CS伴高血压且RAAS受抑制者uEVs中pNKCC2和总/磷酸化NCC较健康对照升高。
  • 血钾(而非尿游离皮质醇)与uEVs中pNKCC2、pNCC和NCC相关。
  • 治疗CS可逆转uEVs中pNKCC2、NCC和pNCC的升高。

核心结论

  • CS伴高血压且RAAS受抑制患者uEVs中肾钠转运蛋白丰度增加,治疗CS可逆转。
  • 低血钾可能参与CS中肾钠重吸收增加和高血压。

研究设计与样本

  • 观察性研究,在大学医院进行。
  • 10例CS伴高血压患者和7名年龄匹配健康对照,uEVs经超离心分离并行免疫印迹分析。
  • 7例CS患者治疗前后分析uEVs。

主要发现

  • 10例CS患者按RAAS受抑制与否分为两组,每组5例。
  • RAAS受抑制组与未受抑制组血压相似,但血清钾显著更低。
  • 与健康对照相比,仅RAAS受抑制组uEVs中pNKCC2及总/磷酸化NCC更高。
  • 血清钾(而非尿游离皮质醇)与uEVs中pNKCC2、pNCC和NCC相关。
  • 治疗CS可逆转uEVs中pNKCC2、NCC和pNCC的升高。

临床怎么用

  • uEVs中肾钠转运蛋白分析可为CS高血压的肾钠重吸收机制提供无创信息。
  • 结果可能也适用于外源性糖皮质激素诱导的高血压。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Increased renal sodium reabsorption contributes to hypertension in Cushing syndrome (CS). Renal sodium transporters can be analyzed noninvasively in urinary extracellular vesicles (uEVs). OBJECTIVE: To analyze renal sodium transporters in uEVs of patients with CS and hypertension. DESIGN: Observational study. SETTING: University hospital. PARTICIPANTS: The uEVs were isolated by ultracentrifugation and analyzed by immunoblotting in 10 patients with CS and 7 age-matched healthy participants. In 7 patients with CS, uEVs were analyzed before and after treatment. MAIN OUTCOME MEASURE: Abundance of protein in uEVs. RESULTS: The 10 patients with CS were divided in those with suppressed and nonsuppressed renin-angiotensin-aldosterone system (RAAS; n = 5 per group). Patients with CS with suppressed RAAS had similar blood pressure but significantly lower serum potassium than patients with CS with nonsuppressed RAAS. Compared with healthy participants, only patients with suppressed RAAS had higher phosphorylated Na+-K+-Cl- cotransporter type 2 (pNKCC2) and higher total and phosphorylated Na+-Cl- cotransporter (pNCC) in uEVs. Serum potassium but not urinary free cortisol correlated with pNKCC2, pNCC, and Na+-Cl- cotransporter (NCC) in uEVs. Treatment of CS reversed the increases in pNKCC2, NCC, and pNCC. CONCLUSIONS: CS increases renal sodium transporter abundance in uEVs in patients with hypertension and suppressed RAAS. Potassium has recently been identified as an important driver of NCC activity, and low serum potassium may also contribute to increased renal sodium reabsorption and hypertension in CS. These results may also be relevant for hypertension induced by exogenous glucocorticoids.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Salih M, Bovée DM, van der Lubbe N, et al. Increased Urinary Extracellular Vesicle Sodium Transporters in Cushing Syndrome With Hypertension. J Clin Endocrinol Metab. 2018. PMID: 29726949. doi:10.1210/jc.2018-00065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。